Research and Markets (http://www.researchandmarkets.com/research/3e7026/partnering_in_the) has announced the addition of the "Partnering in the Global Generics Industry 2009: A Guide to Companies" report to their offering.
Identify merger, acquisition and partner candidates in the rapidly changing global generics market and collaboration runs throughout the generic industry. Here's just a taste of the acquisitions, controlling investments and deals in 2008/09...
- Ascent to acquire Green Cross Pharma of Singapore
- Aurobindo Pharma and Pfizer to commercialise off-patent products
- Biocon and Mylan enter generic biologics development
- Sanitas acquires Homeofarm
- Hovione acquires Pfizer plant in Ireland
- Adcock Ingram tried and failed to acquire Cipla Medpro
- Hi-Tech Pharmacal acquires ECR Pharmaceuticals
- URL Pharma acquires PharmPro manufacturing facility and equipment
Strategic partnering: In addition to outright purchase, strategic partnering or the acquisition of specific drug assets is on the rise as companies seek to bring lower costs and focus to their portfolios. With business cycles growing shorter and shorter, market entry is quicker and more reliable through acquisition and partnering.
The fundamental market drivers are sound: In addition to ongoing expansion, there are other drivers which are causing generic companies to consider the future:
Over the next 5 years over 40 blockbuster pharmaceutical products such as Lipitor, Cozaar, Effexor, Plavix, and Cymbalta will be losing patent protection.
The number of biologics coming into the remit of generic companies is increasing, raising interest in companies with biosimilars production capability.
The branded industry's response: The branded industry continues to vigorously protect its IP and maximise the lifetime value of its products. While legal initiatives will remain a key weapon there will also be commercial responses such as issuing early branded generics, collaborative working with a limited number of generic producers, new formulations or combination products.